Homepage600812 • SHA
add
North China Pharmaceutical Co Ltd
Vorige slotkoers
¥ 6,23
Dag-range
¥ 6,21 - ¥ 6,36
Jaar-range
¥ 4,03 - ¥ 6,91
Gem. volume
35,44 mln.
Koers/winst
134,32
Dividendrendement
0,16%
Primaire beurs
SHA
Marktnieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
(CNY) | sep 2024info | Wijziging j-o-j |
---|---|---|
Opbrengst | 2,33 mld. | -15,04% |
Bedrijfskosten | 539,22 mln. | -19,20% |
Netto inkomsten | 30,48 mln. | 2.035,14% |
Netto winstmarge | 1,31 | 2.520,00% |
Winst per aandeel | — | — |
EBITDA | 362,65 mln. | 6,65% |
Effectief belastingtarief | 32,92% | — |
Balans
Totale activa
Totale passiva
(CNY) | sep 2024info | Wijziging j-o-j |
---|---|---|
Contanten en kortetermijnbeleggingen | 1,72 mld. | 15,99% |
Totale activa | 21,71 mld. | 0,92% |
Totale passiva | 15,10 mld. | -0,95% |
Totaal aandelenvermogen | 6,61 mld. | — |
Uitstaande aandelen | 1,72 mld. | — |
Koers-boekwaardeverhouding | 1,99 | — |
Rendement op activa | 2,06% | — |
Rendement op kapitaal | 2,47% | — |
Kasstroom
Nettomutatie in liquide middelen
(CNY) | sep 2024info | Wijziging j-o-j |
---|---|---|
Netto inkomsten | 30,48 mln. | 2.035,14% |
Operationele kasstroom | 175,21 mln. | -46,70% |
Kasstroom uit beleggingen | -153,19 mln. | 10,80% |
Kasstroom uit financiering | -76,80 mln. | 67,74% |
Nettomutatie in liquide middelen | -55,38 mln. | 30,27% |
Vrije kasstroom | -660,87 mln. | -459,21% |
Over
North China Pharmaceutical Group Corp., is a pharmaceutical manufacturer in China. NCPC was one of the key construction projects during China's First Five-Year Plan. After five years of construction since the foundation date in June 1953, the first successful pharmaceutical production, started in June 1958. Being one of the antibiotic producers both in technology and production scale at that time, NCPC created a history of commercial production of antibiotics in China. It has 45 years of development experience. NCPC has been taking the lead in the Chinese pharmaceutical industry in key economic indexes, ranked as one of the Top500 Enterprises and the best profit-makers in China. By the end of 2002, the total assets of the company were valued at US$2 billion, with 18,500 employees. In 2002, NCPC claimed a domestic sales revenue of US$700 million and export sales of US$100 million. Wikipedia
Opgericht
20 dec 1992
Werknemers
10.159